Mitchell H. Rosner, W. Kline Bolton Kidney International

Slides:

Advertisements

Similar presentations

Hypothesis: an erythropoietin honeymoon phase exists

Advertisements

LDL cholesterol in CKD—to treat or not to treat?

Renal Function Testing

Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction

Anemia management in chronic kidney disease

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Volume 83, Issue 3, Pages (March 2013)

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target Szu-Chun Hung, Der-Cherng Tarng Kidney International

Volume 86, Issue 6, Pages (December 2014)

Volume 61, Issue 2, Pages (February 2002)

Prehypertension and chronic kidney disease: the ox or the plow?

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Reassessment of the care of the patient with chronic kidney disease

John P. Middleton, Patrick H. Pun Kidney International

Burden of chronic kidney disease: North Africa

Francesco Paolo Schena Kidney International

Audit-based education: a potentially effective program for improving guideline achievement in CKD patients Moniek C.M. de Goeij, Joris I. Rotmans Kidney.

Yasuhiro Hamada, Masafumi Fukagawa Kidney International

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 70, Pages S21-S25 (December 2006)

End-stage renal disease in living kidney donors

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Comorbidity and confounding in end-stage renal disease

Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? Gautam R. Shroff, Charles A. Herzog

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Gary C.W. Chan, Sydney C.W. Tang Kidney International

Use of vitamin D in chronic kidney disease patients

Volume 87, Issue 4, Pages (April 2015)

LDL cholesterol in CKD—to treat or not to treat?

Volume 86, Issue 1, Pages (July 2014)

The analysis of survival data: the Kaplan–Meier method

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Fructose intake as a risk factor for kidney stone disease

Response to ‘Hepcidin levels in patients with renal disease’

Volume 73, Issue 12, Pages (June 2008)

Volume 78, Issue 2, Pages (July 2010)

Volume 76, Issue 6, Pages (September 2009)

Günter Weiss, Florian Kronenberg Kidney International

Francesco Locatelli, Lucia Del Vecchio Kidney International

Extracorporeal therapy in sepsis: are we there yet?

Tilman B. Drüeke, Ziad A. Massy Kidney International

Elevated risk of stroke among patients with end-stage renal disease

Methods for guideline development

Volume 87, Issue 1, Pages (January 2015)

Volume 76, Issue 8, Pages (October 2009)

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 74, Issue 5, Pages (September 2008)

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 81, Issue 9, Pages (May 2012)

Prehypertension: is it relevant for nephrologists?

Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell Kara K. Wools-Kaloustian, Samir K. Gupta Kidney.

The Iranian model of living renal transplantation

The Danish Renal Biopsy Register

Volume 80, Issue 10, Pages (November 2011)

Is it the low-protein diet or simply the salt restriction?

Is complement a target for therapy in renal disease?

Volume 75, Issue 7, Pages (April 2009)

Volume 87, Issue 3, Pages (March 2015)

Hisataka Kobayashi, Peter L. Choyke Kidney International

Volume 70, Issue 10, Pages (November 2006)

Volume 88, Issue 5, Pages (November 2015)

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan Yi-Chun.

Stephen Pastan, J. Michael Soucie, William M. McClellan

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

The mortality risk associated with higher hemoglobin: is the therapy to blame? Mitchell H. Rosner, W. Kline Bolton Kidney International Volume 74, Issue 6, Pages 695-697 (September 2008) DOI: 10.1038/ki.2008.263 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 The interplay between factors potentially associated with the increased risk of mortality in CKD/ESRD patients targeted to higher hemoglobin levels. CKD, chronic kidney disease; ESA, erythropoietin-stimulating agent; ESRD, end-stage renal disease. Kidney International 2008 74, 695-697DOI: (10.1038/ki.2008.263) Copyright © 2008 International Society of Nephrology Terms and Conditions